Kyntra Bio, Inc. (KYNB) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.4x

Market Cap

$34.62M

MomentumView details →

1D Return

+0.71%

YTD Return

−4.42%

RSI (14)

67.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.4x

Market Cap

$34.62M

RSI (14)

67.7

MomentumView details →

1D Return

+0.71%

YTD Return

−4.42%

ProfitabilityView details →

Gross Margin

18.15%

Net Margin

3967.77%

EBITDA Margin

−2036.13%

ROE (TTM)

−607.72%

ROA (TTM)

181.24%

Asset Turnover

0.04x

GrowthView details →

Revenue YoY

+106.34%

EPS YoY

+3782.91%

FCF YoY

−60.65%

Revenue CAGR 3Y

−64.23%

EPS CAGR 3Y

+9552.08%

EBITDA YoY

+27.16%

EarningsView details →

EPS (Actual)

$2.96

EPS Surprise

193.08%

Beats (12Q)

4/12

Next Q EPS Est

−$3.66

Avg Surprise (4Q)

47.21%

Rev Surprise

−171.78%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

2.69x

Quick Ratio

2.59x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

4.62M

Net Income (TTM)

183.19M

Op. CF (TTM)

−38.05M

Next earningsNov 9, 2026 →

Latest newsMore news →

Kyntra Bio signed an amendment and restatement of its royalty financing agreement with NQ Project Phoebus, L.P., materially reducing its payment obligations in exchange for an accelerated upfront payment.4d ago

Kyntra Bio reported its financial results for the second quarter of 2026.22d ago

Similar companies

LifeMD, Inc.LFMDP PetMed Express, Inc.PETS 111, Inc.YI Sanai Health Industry Group Company Limited01889.HK Pa Shun International Holdings Limited00574.HK New Ray Medicine International Holding Ltd.06108.HK Find similar companies →

Latest newsMore news →

Kyntra Bio signed an amendment and restatement of its royalty financing agreement with NQ Project Phoebus, L.P., materially reducing its payment obligations in exchange for an accelerated upfront payment.4d ago Kyntra Bio reported its financial results for the second quarter of 2026.22d ago